Blood glucose supplement
This article was originally published in The Tan Sheet
The recently launched OpunDia supplement line contains opuntia ficus-indica, also known as prickly pear cactus, for use in dietary supplements, foods and beverages to support healthy blood glucose levels, Martin Bauer North America announces Dec. 3. OpunDia extract "has been shown in several in-vivo animal studies to be effective in reducing blood glucose levels by as much as 20 percent," the Torrance, Calif.-based firm says, noting the extract is the subject of an ongoing, 16-week, double-blinded, randomized, placebo-controlled clinical study by a university...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.